Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Supplement, 50 Vegetarian Capsules, Gluten Free, Serving Size 2 Capsules. Each product is produced for a specific customer with their distribution information on the label. A general label template was provided with attachment B information. Product is sold in 50 and 100 ct bottles.

Nexgen Pharma, INC. recalled Free Form Amino Acids L-Arginine 7 L-Ornithine Complex With Alpha-Lipoic Acid, Promotes Circulation and Muscle Development, Dietary Suppleme in a Class III action, the FDA tier used when a product is unlikely to cause adverse health effects, typically for labeling or minor regulatory issues on Apr 15, 2013.

The FDA-published reason for this recall is: "Nexgen Pharma is recalling a certain lot of dietary supplement L-Arginine L-Ornithine Alpha Lipoic Acid Capsules due to subpotency of the Alpha Lipoic Acid ingredient."

Distribution was broad: the FDA record describes it as "Distributed to large and small retailers located nationwide as well as two foreign locations (Canada and Netherlands)," which places this among the wider-reach recalls on the site. Consumers across the affected area should check product on hand. The recalling firm is based in Colorado Springs, CO. The recall covers 4571 bottles of product. The FDA has Terminated this recall (first reported May 1, 2013), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.